Data Composite

Recall D-0471-2026

US Class II Ongoing · initiated 2026-03-06

Recalling firm

PAYLESS COMPOUNDERS, LLC, OR

Product

Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR

Reason for recall

Lack of Assurance of Sterility

← All recalls